HARROW, INC. — Director's Dealing 2013

Mar 16, 2013

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-12-31

Reporting Person: Finnegan Paul (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-28	Option (Right to Buy)	$3.2	A	125000	Acquired	2017-01-22	Common Stock (125000)	Direct
2012-04-01	Option (Right to Buy)	$4.5	A	25000	Acquired	2017-03-31	Common Stock (25000)	Direct

Footnotes

F1: The stock option was granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests in three equal annual installments beginning on January 6, 2013. The option was approved by the Issuer's Board of Directors on January 23, 2012, subject to shareholder approval of an amendment to the Plan, which was obtained on February 28, 2012.

F2: The stock option was granted under the Plan and vests in four equal quarterly installments beginning on June 30, 2012.